Comments

Emergent BioSolutions Stock Price, Quotes and Forecasts

Q: What sector and industry does Emergent BioSolutions (EBS) operate in?

Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

EBSNYSE

Logo brought to you by Benzinga Data

Trade with Public

$9.85

-0.42-4.14%

Last update: 1:33 PM

Emergent BioSolutions (EBS) Forecast

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Emergent BioSolutions Stock Price, Quotes and Forecasts | NYSE:EBS | Benzinga

Explore Emergent BioSolutions stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EBS.

Open	$10.00
Close	-
Volume / Avg.	606.37K / 1.25M
Day Range	$9.72 - $10.22
52 Wk Range	4.02 - 13.41
Market Cap	$517.06M
P/E Ratio	7.78
Dividend Yield	-
Exchange	NYSE
RSI	50
Short Interest	16.99%
Days to Cover	10.2

Recent News

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Partner Content

As Mpox Cases Spread Around The World, Tonix Pharmaceuticals' Single-Dose Vaccine TNX-801 Has Potential To Slow The Spread

Stocks Drop As Trade War Escalates: What's Driving Markets Tuesday?

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$10.00
Close	-
Volume / Avg.	606.37K / 1.25M
Day Range	$9.72 - $10.22
52 Wk Range	4.02 - 13.41
Market Cap	$517.06M
P/E Ratio	7.78
Dividend Yield	-
Exchange	NYSE
RSI	50
Short Interest	16.99%
Days to Cover	10.2

About Emergent BioSolutions Inc

Sector

Health Care

Industry

Biotechnology

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Emergent BioSolutions (EBS) stock?

You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.

View our list of the best stock brokerages

Who are Emergent BioSolutions (EBS) competitors?

Other companies in Emergent BioSolutions’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR), Prothena Corp (NASDAQ:PRTA) and ADC Therapeutics (NYSE:ADCT).

What is the forecast, or price target, for Emergent BioSolutions (EBS) stock?

Emergent BioSolutions has a consensus price target of $22.80.

What is the current price for Emergent BioSolutions (EBS)?

The stock price for Emergent BioSolutions (NYSE: EBS) is $9.845 last updated November 7, 2025 at 1:33 PM EST.

Does Emergent BioSolutions (EBS) pay a dividend?

There are no upcoming dividends for Emergent BioSolutions.

When is Emergent BioSolutions (NYSE:EBS) reporting earnings?

Emergent BioSolutions’s Q3 earnings are confirmed for Wednesday, October 29, 2025.

Is Emergent BioSolutions (EBS) going to split?

There is no upcoming split for Emergent BioSolutions.

What sector and industry does Emergent BioSolutions (EBS) operate in?

Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.